Ptc Therapeutics (PTCT) Change in Inventory (2017 - 2026)

Ptc Therapeutics' Change in Inventory history runs 10 years deep, the most recent figure standing at $15.9 million for Q2 2026.

• In Q2 2026, Change in Inventory rose 47.1% year-over-year to $15.9 million; the TTM figure through Jun 2026 stood at $58.5 million (up 9478.07% YoY), while the FY2025 annual figure was $53.9 million, up 974.37% from the prior year.
• Change in Inventory for Q2 2026 stood at $15.9 million, up from -$2.6 million in the prior quarter.
• The five-year high for Change in Inventory was $26.8 million in Q4 2025, with the low at -$11.1 million in Q4 2024.
• The 5-year median for Change in Inventory is $2.5 million (2024), against an average of $4.2 million.
• The sharpest annual moves came in 2023 and 2025: Change in Inventory jumped 1504.64% in 2023, then tumbled 1725.83% in 2025.
• Ptc Therapeutics' Change in Inventory stood at $5.9 million in 2022, then plunged by 200.64% to -$5.9 million in 2023, then slumped by 86.7% to -$11.1 million in 2024, then surged by 341.56% to $26.8 million in 2025, then slumped by 40.77% to $15.9 million in 2026.
• Business Quant data shows PTCT's Change in Inventory at $15.9 million in Q2 2026, -$2.6 million in Q1 2026, and $26.8 million in Q4 2025.